Developing Models to Assess the Impact & Cost-Effectiveness of Targeted Interventions for Tuberculosis

We are seeking fellows with a background in mathematical modeling and cost-effectiveness analysis, and interest in combining these tools with both primary and secondary data sources to answer policy-relevant questions about tuberculosis interventions. Reflecting our team-based, collaborative approach to research, fellows will work with a broader mentorship team, with additional mentors drawn from the Center for Tuberculosis Research and other collaborating teams as appropriate. This fellowship will be funded from a combination of four specific projects (described below), providing flexibility to structure the fellowship around the goals of individual applicants. Successful fellows will help broaden our team’s horizons, enabling us to build new collaborations and explore new research areas. The specific deliverables for this fellowship are linked to ongoing field-based studies with empiric data collection, including:

  1. Models of the impact and cost-effectiveness of school-based screening and prevention in India.
    Estimating the long-term impact and cost-effectiveness of school-based TB disease screening, with or without the addition of preventive therapy for people with infection
  2. Models of the impact and cost-effectiveness of venue-targeted vaccination programs in Zambia, Nigeria, and Indonesia.
    Evaluating whether vaccination is more efficient when delivered at specific venues (e.g., prisons, mines, bars) than to the general population or at health facilities
  3. Models of the impact and cost-effectiveness of novel diagnostic assays for tuberculosis.
    Understanding the importance of different design characteristics and implementation strategies for novel diagnostics, particularly those intended for children, screening, and/or drug susceptibility testing
  4. Models of the impact and cost-effectiveness of drug susceptibility testing for bedaquiline.
    Forecasting the future and health impact of bedaquiline-resistant TB under different scenarios of availability and scale-up of drug susceptibility testing in key countries
Type
Postdoc
Institution
Johns Hopkins Bloomberg School of Public Health
City
Baltimore
Country
United States
Closing date
February 13th, 2026
Posted on
January 22nd, 2026 10:10
Last updated
January 23rd, 2026 19:59
Share